Patents by Inventor Bishwagit Nag

Bishwagit Nag has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Heterocyclic analogs of diphenylethylene compounds
    Patent number: 7718682
    Abstract: Novel diphenylethylene compounds and derivatives thereof containing thiazolidinedione or oxazolidinedione moieties are provided which are effective in lowering blood glucose level, serum insulin, triglyceride and free fatty acid levels in animal models of Type II diabetes. The compounds are disclosed as useful for a variety of treatments including the treatment of inflammation, inflammatory and immunological diseases, insulin resistance, hyperlipidemia, coronary artery disease, cancer and multiple sclerosis.
    Type: Grant
    Filed: April 2, 2008
    Date of Patent: May 18, 2010
    Assignee: Theracos, Inc.
    Inventors: Partha Neogi, Debendranath Dey, Satyanarayana Medicherla, Bishwagit Nag, Arthur Lee
  • Novel dipheylenthylene compounds
    Publication number: 20040259938
    Abstract: Novel dephenylethylene compounds that are administered orally to decrease circulating concentrations of glucose are provided. The effect on insulin resistant rats is also shown. The effects on lipid and leptin concentrations are also shown. The compounds are orally effective anti-diabetic agents that may normalize glucose and lipid metabolism in subjects with diabetes.
    Type: Application
    Filed: October 23, 2003
    Publication date: December 23, 2004
    Inventors: Bishwagit Nag, Debendranath Dey, Satyanarayana Medicherla, Partha Neogi
  • Novel diphenylethylene compounds
    Publication number: 20020002200
    Abstract: Novel dephenylethylene compounds that are administered orally to decrease circulating concentrations of glucose are provided. The effect on insulin resistant rats is also shown. The effects on lipid and leptin concentrations are also shown. The compounds are orally effective anti-diabetic agents that may normalize glucose and lipid metabolism in subjects with diabetes.
    Type: Application
    Filed: February 5, 2001
    Publication date: January 3, 2002
    Inventors: Bishwagit Nag, Debendranath Dey, Satyanarayana Medicherla, Partha Neogi